Designed to streamline pharmacy stocking and improve patient access, the compact size features the exact same formulation and cost per mL.

Data from the phase 3 BASIS and BASIS KIDS trials support the expanded indication of this once-weekly subcutaneous non-factor therapy down to age 6.

Data show that orforglipron, a once-daily oral GLP-1 receptor agonist, drives significant, long-term weight reduction in women with obesity or overweight across all 3 stages of menopause: premenopause ...

Kennedy and his advisers have been frustrated that federal access to Americans’ medical records has been limited.

"[These patients] are absent from the diagnostic code that would identify them as long COVID patients." HealthDay News — About 16% of COVID-19 cases develop postacute sequelae of severe acute ...

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

Zaynich is a combination of cefepime, a cephalosporin antibacterial, and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial.

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...

Ranluspec is the only interchangeable ranibizumab biosimilar approved in both vial and prefilled syringe presentations.

At Michigan schools where only 30% to 40% of students are now vaccinated, it is “simply not possible to keep diseases like measles at bay." ...